Radioimmunotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage IV Breast Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

May 31, 1998

Primary Completion Date

May 31, 2002

Conditions
Breast Cancer
Interventions
BIOLOGICAL

filgrastim

as prescribed by physician

PROCEDURE

autologous bone marrow transplantation

1-2 weeks prior to treatment

PROCEDURE

peripheral blood stem cell transplantation

1-2 weeks prior to treatment

RADIATION

yttrium Y 90 monoclonal antibody MN-14

intravenous infusion over 30 min, single dose

Trial Locations (3)

19104

University of Pennsylvania Cancer Center, Philadelphia

07103

Garden State Cancer Center, Belleville

07503

St. Joseph's Hospital and Medical Center, Paterson

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Garden State Cancer Center at the Center for Molecular Medicine and Immunology

OTHER

NCT00004085 - Radioimmunotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage IV Breast Cancer | Biotech Hunter | Biotech Hunter